PL2336172T3 - Usuwanie agregatów o dużej masie cząsteczkowej przy użyciu chromatografii hydroksyapatytowej - Google Patents

Usuwanie agregatów o dużej masie cząsteczkowej przy użyciu chromatografii hydroksyapatytowej

Info

Publication number
PL2336172T3
PL2336172T3 PL10174366T PL10174366T PL2336172T3 PL 2336172 T3 PL2336172 T3 PL 2336172T3 PL 10174366 T PL10174366 T PL 10174366T PL 10174366 T PL10174366 T PL 10174366T PL 2336172 T3 PL2336172 T3 PL 2336172T3
Authority
PL
Poland
Prior art keywords
removal
molecular weight
high molecular
hydroxyapatite chromatography
weight aggregates
Prior art date
Application number
PL10174366T
Other languages
English (en)
Inventor
Shujun Sun
Christopher Gallo
Brian Kelley
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL2336172T3 publication Critical patent/PL2336172T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/04—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of alkali metals, alkaline earth metals or magnesium
    • B01J20/048—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of alkali metals, alkaline earth metals or magnesium containing phosphorus, e.g. phosphates, apatites, hydroxyapatites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
PL10174366T 2003-10-27 2004-10-06 Usuwanie agregatów o dużej masie cząsteczkowej przy użyciu chromatografii hydroksyapatytowej PL2336172T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51401803P 2003-10-27 2003-10-27
US52333503P 2003-11-20 2003-11-20
EP10174366.4A EP2336172B1 (en) 2003-10-27 2004-10-06 Removal of high molecular weight aggregates using hydroxyapatite chromatography
EP04794288.3A EP1678208B1 (en) 2003-10-27 2004-10-06 Removal of high molecular weight aggregates using hydroxyapatite chromatography

Publications (1)

Publication Number Publication Date
PL2336172T3 true PL2336172T3 (pl) 2015-04-30

Family

ID=34576743

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10174366T PL2336172T3 (pl) 2003-10-27 2004-10-06 Usuwanie agregatów o dużej masie cząsteczkowej przy użyciu chromatografii hydroksyapatytowej
PL04794288T PL1678208T3 (pl) 2003-10-27 2004-10-06 Usuwanie agregatów o wysokiej masie cząsteczkowej z użyciem chromatografii na hydroksyapatycie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL04794288T PL1678208T3 (pl) 2003-10-27 2004-10-06 Usuwanie agregatów o wysokiej masie cząsteczkowej z użyciem chromatografii na hydroksyapatycie

Country Status (19)

Country Link
US (2) US9469672B2 (pl)
EP (2) EP1678208B1 (pl)
JP (2) JP5004586B2 (pl)
KR (2) KR101321876B1 (pl)
CN (2) CN102276717B (pl)
AU (1) AU2004286938B2 (pl)
BR (2) BR122020007658B1 (pl)
CA (1) CA2543193C (pl)
CO (1) CO5690649A2 (pl)
DK (2) DK2336172T3 (pl)
EC (1) ECSP066583A (pl)
ES (2) ES2530446T3 (pl)
IL (1) IL175229A (pl)
MX (1) MXPA06004472A (pl)
NZ (1) NZ547315A (pl)
PL (2) PL2336172T3 (pl)
PT (2) PT1678208E (pl)
RU (2) RU2409591C2 (pl)
WO (1) WO2005044856A2 (pl)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304576D0 (en) * 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
EP1678208B1 (en) * 2003-10-27 2013-05-15 Wyeth LLC Removal of high molecular weight aggregates using hydroxyapatite chromatography
RU2457214C2 (ru) 2005-03-11 2012-07-27 Вайет Способ хроматографии в режиме слабого распределения
WO2006138553A2 (en) 2005-06-17 2006-12-28 Wyeth Methods of purifying fc region containing proteins
WO2007002543A2 (en) * 2005-06-23 2007-01-04 Medimmune, Inc. Antibody formulations having optimized aggregation and fragmentation profiles
PE20070796A1 (es) * 2005-10-24 2007-08-15 Wyeth Corp Metodo de produccion proteica utilizando compuestos anti-senescencia
US7390786B2 (en) * 2005-12-21 2008-06-24 Wyeth Protein formulations with reduced viscosity and uses thereof
JPWO2007123242A1 (ja) 2006-04-25 2009-09-10 東ソー株式会社 ＩｇＧ精製用分離剤、及びそれを用いたＩｇＧ単量体の精製方法
WO2009017491A1 (en) * 2006-06-14 2009-02-05 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
NZ574623A (en) * 2006-08-28 2011-12-22 Ares Trading Sa Process for the purification of fc-fusion proteins
SI2061803T2 (sl) 2006-08-28 2023-01-31 Ares Trading S.A. Postopek za čiščenje proteinov, ki vsebujejo FC
RU2009106083A (ru) * 2006-09-08 2010-10-20 Вайет (Us) Аргининовая промывка для очистки белков с использованием аффинной хроматографии
EP2064314A4 (en) 2006-09-13 2009-12-30 Abbott Lab IMPROVEMENTS TO CELL CULTURE
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
ES2366593T3 (es) * 2007-01-26 2011-10-21 Merck Serono S.A. Purificación de proteínas de fusión taci-fc empleando la tecnología de cuerpos grasos.
CA2703086C (en) * 2007-10-26 2014-11-25 Asahi Kasei Chemicals Corporation Method for purifying protein
CA2720615C (en) 2008-04-08 2016-06-07 Bio-Rad Laboratories, Inc. Chromatography purification of antibodies
SI2848625T1 (sl) † 2008-08-14 2019-11-29 Genentech Inc Postopki za odstranjevanje kontaminanta z uporabo ionskoizmenjevalne membranske kromatografije z izpodrinjenjem nativnega proteina
EP2350127B1 (en) 2008-10-20 2015-01-28 AbbVie Inc. Isolation and purification of antibodies using protein a affinity chromatography
BRPI0920572A8 (pt) 2008-10-20 2015-10-27 Abbott Lab Inativação viral durante a purificação dos anticorpos
CA2738243C (en) 2008-10-29 2020-09-29 Wyeth Llc Formulations of single domain antigen binding molecules
CN105646643A (zh) * 2008-10-29 2016-06-08 阿布林克斯公司 单域抗原结合性分子的纯化方法
EP2350130B1 (en) * 2008-10-31 2018-10-03 Wyeth LLC Purification of acidic proteins using ceramic hydroxyapatite chromatography
CA2751000A1 (en) * 2009-03-11 2010-12-23 Wyeth Llc Methods of purifying small modular immunopharmaceutical proteins
CA2759502C (en) 2009-04-29 2021-02-09 Bio-Rad Laboratories, Inc. Purification of immunoconjugates
JPWO2011001963A1 (ja) 2009-07-03 2012-12-13 旭化成ケミカルズ株式会社 多孔質基材に固定されたグラフト鎖に結合しているアミノ基及びアルキル基を有する多孔膜を用いた抗体の精製方法
US8491904B2 (en) * 2009-10-20 2013-07-23 Abbvie Inc. Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
LT2513134T (lt) 2009-12-18 2017-11-27 Novartis Ag Praplovimo tirpalas ir afininės chromatografijos metodas
EP2519537A4 (en) * 2009-12-29 2013-07-10 Reddys Lab Ltd Dr CLEANING PROTEINS
JP5773454B2 (ja) * 2010-01-15 2015-09-02 バイオ−ラッド ラボラトリーズ インコーポレーティッド アパタイトの表面中和方法
MX2012011737A (es) * 2010-04-14 2012-11-16 Hoffmann La Roche Remocion de agregado de inmunoglobulina.
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
WO2011156073A1 (en) * 2010-06-08 2011-12-15 Millipore Corporation Removal of protein aggregates from biopharmaceutical preparations using calcium phosphate salts
US8895707B2 (en) * 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
EP2635599A1 (en) 2010-11-01 2013-09-11 DSM IP Assets B.V. Single unit ion exchange chromatography antibody purification
CA2825651C (en) 2011-02-02 2020-03-24 Bio-Rad Laboratories, Inc. Apatite surface neutralization with alkali solutions
US9809639B2 (en) * 2011-06-08 2017-11-07 Agency For Science, Technology And Research Purification of biological products by constrained cohydration chromatography
EA201400024A1 (ru) * 2011-06-16 2014-04-30 ДСМ АйПи АССЕТС Б.В. Хроматографическая очистка антитела в одном устройстве
SG10201701224UA (en) * 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
US9815695B2 (en) 2012-05-30 2017-11-14 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
WO2014003142A1 (ja) * 2012-06-27 2014-01-03 旭化成メディカル株式会社 抗体
JP2014105180A (ja) * 2012-11-27 2014-06-09 Hoya Corp モノマー化方法
AU2014243839B2 (en) 2013-03-13 2019-01-03 Buzzard Pharmaceuticals AB Chimeric cytokine formulations for ocular delivery
WO2014209508A1 (en) * 2013-05-13 2014-12-31 Medimmune, Llc Separation of recombinant polyclonal antibody multimers with minimal separation of monomers
US10611826B2 (en) 2013-07-05 2020-04-07 Laboratoire Français Du Fractionnement Et Des Biotechnologies Affinity chromatography matrix
JP6479305B2 (ja) * 2013-07-12 2019-03-06 株式会社Ｕｍｎファーマ ウイルス様粒子の精製方法
US10519194B2 (en) 2013-07-12 2019-12-31 Merck Patent Gmbh Removal of fragments from a sample containing a target protein using activated carbon
JP6326499B2 (ja) 2013-12-12 2018-05-16 イー・エム・デイー・ミリポア・コーポレイシヨン アクリルアミド含有フィルターを使用したタンパク質分離
CN106029682B (zh) 2013-12-27 2021-04-13 中外制药株式会社 等电点低的抗体的纯化方法
CN105392569B (zh) 2014-06-23 2019-08-20 生物辐射实验室股份有限公司 磷灰石预处理
US10092857B2 (en) 2014-06-23 2018-10-09 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
EP3233230A1 (en) 2014-12-15 2017-10-25 Merck Patent GmbH Target molecule capture from crude solutions
WO2016149088A1 (en) 2015-03-13 2016-09-22 Bristol-Myers Squibb Company Use of alkaline washes during chromatography to remove impurities
WO2017109619A1 (en) 2015-12-21 2017-06-29 Pfizer Inc. Purification of antibody drug conjugates using a sodium phosphate gradient
US11186858B1 (en) 2016-03-15 2021-11-30 Fresenius Kabi Deutschland Gmbh Methods for increasing biosimilarity
US11919924B1 (en) * 2016-03-15 2024-03-05 Fresenius Kabi Deutschland Gmbh Methods of purifying and producing an adalimumab antibody
CN106977591B (zh) * 2017-05-04 2020-05-05 广州康盛生物科技股份有限公司 一种分离纯化重组葡萄球菌蛋白a的方法
US11697670B2 (en) 2017-08-22 2023-07-11 Biogen Ma Inc. Methods for purifying antibodies having reduced high molecular weight aggregates
WO2019116096A1 (en) * 2017-12-15 2019-06-20 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Production of fc fragments
CA3034795A1 (en) * 2018-02-27 2019-08-27 Pfizer Inc. Antibody purification
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
US20210024573A1 (en) 2018-04-03 2021-01-28 Merck Patent Gmbh Cex chromatography media and low salt elution of target proteins from biopharmaceutical feeds
WO2019224660A1 (ja) * 2018-05-24 2019-11-28 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 吸着剤の生産方法
EP4061825A1 (en) 2019-11-22 2022-09-28 MorphoSys AG Method to increase antibody yield during ion exchange chromatography
JP2020099909A (ja) * 2020-03-17 2020-07-02 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 処理方法、生産方法およびハイドロキシアパタイト充填剤
CN115397868A (zh) 2020-03-30 2022-11-25 埃博灵克斯股份有限公司 用于产生和纯化多价免疫球蛋白单可变域的方法
AU2021262609A1 (en) * 2020-05-01 2022-12-22 Kashiv Biosciences, Llc An improved process of purification of protein

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US514018A (en) 1894-02-06 Edward j
US428894A (en) 1890-05-27 Process of making tool-handles
US523335A (en) 1894-07-24 Air-bolt for flour-mills
US419964A (en) 1890-01-21 Transom-lifter
US4745183A (en) * 1984-02-21 1988-05-17 Bio-Rad Laboratories, Inc. Use of hydroxylapatite for the analysis and preparation of purified monoclonal antibodies
JPH03291300A (ja) * 1989-12-28 1991-12-20 Mitsui Toatsu Chem Inc ポリクローナル抗体の分離方法
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
PE20020574A1 (es) * 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
ES2322945T5 (es) 2001-12-21 2012-10-17 Immunex Corporation Métodos para purficación de proteína
DK1601697T3 (da) 2003-02-28 2007-10-01 Lonza Biologics Plc Oprensning af antistof ved protein A- og ionbytningskromatografi
EP1678208B1 (en) * 2003-10-27 2013-05-15 Wyeth LLC Removal of high molecular weight aggregates using hydroxyapatite chromatography

Also Published As

Publication number Publication date
CA2543193A1 (en) 2005-05-19
RU2409591C2 (ru) 2011-01-20
KR20120003027A (ko) 2012-01-09
JP2012111769A (ja) 2012-06-14
ES2530446T3 (es) 2015-03-02
CA2543193C (en) 2015-08-11
IL175229A0 (en) 2006-09-05
EP2336172A1 (en) 2011-06-22
KR20060120163A (ko) 2006-11-24
RU2573910C2 (ru) 2016-01-27
JP5004586B2 (ja) 2012-08-22
DK2336172T3 (en) 2015-01-26
RU2010139827A (ru) 2012-03-27
CN1898266B (zh) 2011-09-21
NZ547315A (pl) 2008-07-31
BR122020007658B1 (pt) 2021-07-27
PT2336172E (pt) 2015-02-20
AU2004286938B2 (en) 2011-06-30
EP2336172B1 (en) 2014-12-10
CN102276717B (zh) 2015-09-09
KR101221862B1 (ko) 2013-01-14
PT1678208E (pt) 2013-07-10
RU2006113695A (ru) 2007-12-10
JP2007532477A (ja) 2007-11-15
MXPA06004472A (es) 2006-06-20
DK1678208T3 (da) 2013-07-08
CN102276717A (zh) 2011-12-14
US20050107594A1 (en) 2005-05-19
BRPI0415887A (pt) 2007-01-09
US20130197198A1 (en) 2013-08-01
KR101321876B1 (ko) 2013-10-28
EP1678208A2 (en) 2006-07-12
CN1898266A (zh) 2007-01-17
PL1678208T3 (pl) 2013-09-30
ES2418830T3 (es) 2013-08-16
AU2004286938A1 (en) 2005-05-19
ECSP066583A (es) 2006-10-17
IL175229A (en) 2013-08-29
BRPI0415887B1 (pt) 2021-01-26
CO5690649A2 (es) 2006-10-31
US9822143B2 (en) 2017-11-21
WO2005044856A3 (en) 2005-06-23
WO2005044856A2 (en) 2005-05-19
EP1678208B1 (en) 2013-05-15
US9469672B2 (en) 2016-10-18
JP5490156B2 (ja) 2014-05-14

Similar Documents

Publication Publication Date Title
IL175229A0 (en) Removal of high molecular weight aggregates using hydroxyapatite chromatography
AU2003268210A8 (en) Chromatographic methods for adenovirus purification
IL172030A0 (en) Hydrogel composition demonstrating phase separation
EP1556428A4 (en) COMPOSITIONS CURING RAPIDLY
EP1630186A4 (en) HARDENING COMPOSITION
AU2003259290A8 (en) Glass compositions
GB0310767D0 (en) Stick compositions
EP1640391A4 (en) HARDENING COMPOSITION
HRP20030824A2 (en) Phenyl heterocyclyl ether derivatives as serotoninre-uptake inhibitors
PT1842550E (pt) Composição para indução de imunotolerância
GB0310771D0 (en) Stick compositions
GB0318824D0 (en) Novel composition
GB0305790D0 (en) Novel Composition
IL175678A0 (en) Novel piperidine-substituted indoles-or heteroderivatives thereof
HUP0600231A2 (en) Novel process for the preparation of 2h-chromenes
SI1678208T1 (sl) Odstranjevanje agregatov z visoko molekulsko maso z uporabo hidroksiapatitne kromatografije
GB0310769D0 (en) Stick compositions
GB0324574D0 (en) Novel compositions
GB0328023D0 (en) Novel compositions
AU152108S (en) Set of pavers
HUE036242T2 (hu) Eljárás cefradin elõállítására
GB0225021D0 (en) Rubber compositions
GB2397354B (en) Mounting apparatus of two members
GB0314836D0 (en) Novel compositions
PL363422A1 (pl) Sposób modyfikacji cząsteczki chemicznej